OpGen Unyvero - Model LRT Panels - Unyvero Lower Respiratory
From Unyvero
The FDA-cleared Unyvero LRT panels enable unique and comprehensive detection of the most clinically relevant pathogens and antibiotic resistance markers that cover more than 90% of the most common causative agents of pneumonia, providing clinicians with rapid diagnostic results to enable earlier targeted treatment and drive better patient outcomes.
Product Details
- Tests direct from native specimen, no growth required
- Sample-to-answer under 5 hours, just 2 minutes of hands-on time
- Simultaneously tests for 30 targets that can cause pneumonia, including Pneumocystis jirovecii
- Simple, clear, qualitative results based on defined cut-offs
- Actionable results for faster targeted antibiotic therapy
Pneumonia can be fatal
Pneumonia, a leading cause of death in critically ill patients, increases the length of hospitalization by an average of 5.5 days and adds significantly to the cost of hospital care by approximately $40,000. Diagnosis is difficult and patients are frequently over-treated empirically with broad-spectrum antibiotics due to delayed definitive diagnosis. Therefore, early diagnosis of life-threatening bacterial lower respiratory infections is crucial for optimal treatment and prevention strategies.
- 50% of patients that died from COVID-19 had secondary infections2
- Mechanical ventilation exacerbates the risk of bacterial infections3
- Reported co-infections include Acinetobacter, Klebsiella, Mycoplasma and Legionella4
Unyvero LRT Panels provide results days faster tha...
Unyvero LRT Panels provide results days faster than culture, reducing clinician wait time to optimize antibiotic therapy
Pneumonia is often treated empirically with antibiotics. The slow turn-around-time of current laboratory methods may lead to delays in appropriate antimicrobial therapy, potentially contributing to patient harm and to rising costs of healthcare and excessive use of broad-spectrum antibiotics.
As with other serious infections, the key for effective treatment is the early diagnosis of pathogens and associated resistance markers. This allows targeted treatment, better use of available antibiotics, decreased length of hospital stays, and lower healthcare costs.
The Unyvero LRT panel approach simultaneously identifies a broad spectrum of clinically relevant pathogens and antibiotic resistance markers associated with lower respiratory tract infections such as pneumonia in less than 5 hours directly from native specimen.
Comprehensive results in a single rapid test.
Customer reviews
No reviews were found for OpGen Unyvero - Model LRT Panels - Unyvero Lower Respiratory. Be the first to review!